Last reviewed · How we verify
NCT06965816
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
trial in Alzheimer's Disease in 85 participants. Completed in 24 May 2023.
24 May 2023
Quick facts
| Lead sponsor | Centre Hospitalier de Saint-Denis |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 85 |
| Start date | 24 November 2022 |
| Primary completion | 24 May 2023 |
| Estimated completion | 24 May 2023 |
| Sites | 1 location across France |
Conditions studied
- Alzheimer's Disease — all drugs for Alzheimer's Disease →
- Hippocampus — all drugs for Hippocampus →
- Brain Atrophy — all drugs for Brain Atrophy →
- Magnetic Resonance Imaging — all drugs for Magnetic Resonance Imaging →
Sponsor
Centre Hospitalier de Saint-Denis
Who can join
Eligibility, any sex, with Alzheimer's Disease or Hippocampus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to better understand Alzheimer's disease by looking at brain scans, specifically MRI images, to detect early signs of brain changes linked to the disease. Researchers are focusing on the hippocampus, a part of the brain that shrinks in people with Alzheimer's. The study will also explore other brain changes that often happen alongside hippocampal shrinkage. By analyzing these brain images, the study hopes to find ways to diagnose Alzheimer's earlier and more accurately using advanced imaging techniques.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06965816
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alzheimer's Disease
Currently open trials in the same condition.
- NCT07027072 — Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment · Phase 2 · recruiting
- NCT07138677 — Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial · NA · recruiting
- NCT06965062 — Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study) · NA · recruiting
- NCT06871839 — The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease · recruiting
- NCT07205003 — Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders · recruiting
Other Centre Hospitalier de Saint-Denis trials
Trials by the same sponsor.
- NCT07204626 — Medical Anthropology and Migrants in Precarious Situations, Cared for in Intensive and Post-intensive Care Units · not yet recruiting
- NCT07206914 — Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital · not yet recruiting
- NCT07200999 — Prevalence of Carriage of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteria in Preterm Premature Rupture · not yet recruiting
- NCT07170137 — Comparison of Uterine Distension in Hysterosonography Among Patients Monitored for Infertility · recruiting
- NCT07061561 — Objective Evaluation of Cough Effort in Tracheotomized Patients (LOST Study) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06965816 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Saint-Denis
- Last refreshed: 11 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06965816.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing